#7 Studying Psychedelics, Sex, and More with fMRI Imaging – Dr. Matthew Wall, Neuroscientist
Listen now
Description
Interview with Dr. Matthew Wall. He is a neuroscientist, psychologist, and fMRI (brain imaging) specialist with Imperial College London and Invicro (a CRO focused on medical imaging). His research has explored the domains of neuropsychopharmacology, addiction, psychedelics, cannabis, sex hormones, pain, weight loss, and much more.  We discuss Dr. Wall’s journey into the field, his recent projects, innovations in fMRI & medical imaging, how AI is going to change everything, and the future of neurotech.  Recorded January 11, 2024. Host: Robert Murcko     Key Moments 0:00 Intro 3:56 What are you working on now? (Sex, Cannabis, Psychedelics, and more) 15:26 Scientific Theories Behind Psychedelic Applications in Mental Health 19:18 FDA and Psychedelics 20:36 Innovations in fMRI Imaging Over the Years 24:50 Contribution of AI to fMRI and Neuroimaging Innovation 26:53 Background on Data Streams an fMRI Scanner Provides 29:14 PETxfMRI & EEGxfMRI 32:25 fMRI Brain-Computer Interfaces 35:16 Related modalities: fNIRS, MEG 36:12 Minimizing fMRI and why its so large 37:49 Bedside fMRI 38:11 Predictions for the Future of Neurotech and fMRI 45:21 Conclusion and Contact Information   Links Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe   Dr. Wall’s Link Tree: https://linktr.ee/mbwall
More Episodes
Published 10/24/24
Key Moments 0:00 Lee Sidebottom Introduction: Director of Concept Applications at NeuroTracker 5:29 Initial Interest in Neuroscience 12:14 Brain Imaging Technologies Utilized: Currently qEEG. fMRI in Future? 14:55 Early Technology Transfer and Living with CEO 19:52 What is NeuroTracker...
Published 10/24/24
Nao Yukawa is a founder of the startup DeMind. Their main product is an app called Lifestack which helps you “Schedule Your Day with Energy in Mind” by using physiological data from your wearables and contextual data from your calendar and other sources.  Nao and his cofounders at DeMind have had...
Published 10/19/24